Benefits of biomarker selection and clinico-pathological covariate inclusion in breast cancer prognostic models

INTRODUCTION: Multi-marker molecular assays have impacted management of early stage breast cancer, facilitating adjuvant chemotherapy decisions. We generated prognostic models that incorporate protein-based molecular markers and clinico-pathological variables to improve survival prediction. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Parisi, Fabio, González, Ana M, Nadler, Yasmine, Camp, Robert L, Rimm, David L, Kluger, Harriet M, Kluger, Yuval
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096952/
https://www.ncbi.nlm.nih.gov/pubmed/20809974
http://dx.doi.org/10.1186/bcr2633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096952/
https://www.ncbi.nlm.nih.gov/pubmed/20809974
http://dx.doi.org/10.1186/bcr2633

Ejemplares similares